Hostname: page-component-7b7567c8c-48dgx Total loading time: 0 Render date: 2026-11-18T09:52:41.746Z Has data issue: false hasContentIssue false

Live influenza B vaccine in volunteers

A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines*

Published online by Cambridge University Press:  15 May 2009

A. S. Beare
Affiliation:
Common Cold Research Unit, Salisbury
D. A. J. Tyrrell
Affiliation:
Common Cold Research Unit, Salisbury
D. Hobson
Affiliation:
Bacteriology Department, University of Liverpool
C. H. L. Howells
Affiliation:
Virus Laboratory, New Cross Hospital, Wolverhampton
M. S. Pereira
Affiliation:
Central Public Health Laboratory, Colindale, London, N.W.9
T. M. Pollock
Affiliation:
Central Public Health Laboratory, Colindale, London, N.W.9
L. E. Tyler
Affiliation:
General Practitioner, Wolverhampton
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

A trial of an experimental live influenza B vaccine has been described.

The virus it contained was active and produced infections, antibody rises and clinical reactions.

Second and third vaccinations had much less effect than the first. Resistance to revaccination was only partially reflected in the serological response.

It seems that another factor, probably local antibody, exerts a considerable influence on resistance to infection with influenza viruses.

We are greatly indebted to Dr P. G. Higgins of the Public Health Laboratory, Cirencester, who went to much trouble to provide us with specimens from patients with influenza; to Dr H. G. Pereira of the National Institute for Medical Research for the antigenic analysis of the vaccine virus; to Messrs Sankey Ltd., Bilston, Wolverhampton, for their unfailing courtesy and forbearance throughout the trial; to the volunteers for their enthusiastic co-operation in the face of some discom forts; and to Messrs Pfizer Ltd., Sandwich, for originally providing facilities for the preparation of the vaccine.

In particular we wish to record our gratitude for the invaluable technical help of Miss Pamela Ball of the Common Cold Research Unit, Mrs Maria Gregory of the Bacteriology Department of Liverpool University, Mrs L. Johnson of the Virus Laboratory of New Cross Hospital, Wolverhampton, and Mr A. Westoby, an assistant in the practice of Dr Tyler.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1969